trending Market Intelligence /marketintelligence/en/news-insights/trending/jfC0Fe0Ji06qHYzRuua3OQ2 content esgSubNav
In This List

Ampio Pharmaceuticals appoints interim CFO

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise


Ampio Pharmaceuticals appoints interim CFO

Ampio Pharmaceuticals Inc. opted against renewing the employment agreement of Gregory Gould, its CFO.

The biopharmaceutical company instead tapped its controller, Tom Chilcott, to take over Gould's duties on an interim basis.

Gould had been serving as the CFO of Ampio and Aytu BioScience Inc. since April 2015.